Elagolix treatment in women with heavy menstrual bleeding associated with uterine fibroid: a systematic review and meta-analysis.

Juliawati Muhammad Yusnita Yusof Imran Ahmad Norhayati Mohd Noor

Published in: BMC women's health (2022)

Elagolix appeared to be effective in reducing heavy menstrual bleeding caused by uterine fibroid and combination with estradiol/norethindrone acetate was able to alleviate the hypoestrogenism side effects in premenopausal women. Review registration PROSPERO CDR 42021233898.

Keyphrases

atrial fibrillation
polycystic ovary syndrome
breast cancer risk
type diabetes
adipose tissue
metabolic syndrome
combination therapy
insulin resistance
smoking cessation
cervical cancer screening